Arrowhead Research | ARWR - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Anika Therapeutics USD 41.02M 16.46M 2026-03
Arrowhead Research USD 201.64M 112.94M 2025-12
Heron Therapeutics USD 26.12M 2.53M 2026-03
Incyte USD 4.02B 435.22M 2026-03
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Merck USD 5.33B 9.24B 2026-03
Moderna USD 1.91B 687M 2026-03
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Sarepta Therapeutics USD 464.45M 336.83M 2026-03
TG Therapeutics USD 442.21M 242.7M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Xencor USD 14.17M 39.9M 2026-03